The medical technology firm Becton, Dickenson and Co. has agreed to sell most of its Billerica, Mass.-based Discovery Labware unit to specialty glass and ceramics maker Corning for $730 million, according to a news release.
Corning to acquire most of Discovery Labware
The cash deal will increase revenue for Corning and its life science unit, said Wendell Weeks, the company's CEO, president and chairman, in the release. The deal, which the company said is expected to augment global market access and enhance life science products for Corning, is subject to customary closing conditions and it expected to close by the end of the year, according to the release. Discovery Labware operates in Massachusetts, North Carolina and the U.K., the release said.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.